Patents by Inventor Anil Kumar Katare

Anil Kumar Katare has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250312357
    Abstract: The present invention relates to the process of enrichment of Phytocannabinoids namely CBD and ?9-THC from the dried aerial part (leaves and inflorescence) of Cannabis sativa. The present invention also relates to the preparation of formulation having enriched CBD and THC by combining with appropriate acceptable excipients such as nutriose, dextrin and maltodextrin. The present invention also discloses the use of the phytocannabanoids enriched blend for the management of pain including cancer pain & general pain.
    Type: Application
    Filed: May 16, 2023
    Publication date: October 9, 2025
    Applicant: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Pankaj Singh CHAM, Manmeet SINGH, Aman VERMA, Radhika ANAND, Rohit SINGH, Kuhu SHARMA, Pankul KOTWAL, Abhishek GOUR, Pankaj KUMAR, Durga Prasad MINDALA, Sumit ROY, Chandra Pal SINGH, Siya Ram MEENA, Ajay KUMAR, Mahendra Kumar VERMA, Vishav Prakash RAHUL, Utpal NANDI, Sumeet GAIROLA, Anil Kumar KATARE, Deepika SINGH, Pyare Lal SANGWAN, Dhiraj VYAS, Sanghapal Damodhar SAWANT, Gurdarshan SINGH, Vishwakarma Ram ASREY, Dumbala Srinivasa REDDY, Parvinder Pal SINGH
  • Patent number: 11446346
    Abstract: The present invention is related to a novel gastroretentive swellable oral dosage form for sustained or delayed release of bergenin, a active constituent of Bergenia ciliata extract/fraction and a process for preparing the same wherein the extract is wet-granulated using excipients i.e. biodegradable polymers and/or non-biodegradable polymers alone or in combination, and the said granules are either filled into a capsule or compressed into a tablet. The said formulation comprising a granulated extract of bergenin-rich Bergenia ciliata with polymers has resulted in a sustained release of extract in the stomach over a period of 16-24 hrs. The said formulations are useful for the treatment of inflammatory diseases.
    Type: Grant
    Filed: September 11, 2018
    Date of Patent: September 20, 2022
    Assignee: Council of Scientific & Industrial Research
    Inventors: Sonali Sandip Bharate, Rohit Singh, Mehak Gupta, Bikarma Singh, Anil Kumar Katare, Ajay Kumar, Sandip Bibishan Bharate, Ram Vishwakarma
  • Publication number: 20200316150
    Abstract: The present invention is related to a novel gastroretentive swellable oral dosage form for sustained or delayed release of bergenin, a active constituent of Bergenia ciliata extract/fraction and a process for preparing the same wherein the extract is wet-granulated using excipients i.e. biodegradable polymers and/or non-biodegradable polymers alone or in combination, and the said granules are either filled into a capsule or compressed into a tablet. The said formulation comprising a granulated extract of bergenin-rich Bergenia ciliata with polymers has resulted in a sustained release of extract in the stomach over a period of 16-24 hrs. The said formulations are useful for the treatment of inflammatory diseases.
    Type: Application
    Filed: September 11, 2018
    Publication date: October 8, 2020
    Inventors: Sonali Sandip Bharate, Rohit Singh, Mehak Gupta, Bikarma Singh, Anil Kumar Katare, Ajay Kumar, Sandip Bibishan Bharate, Ram Vishwakarma